Pharmacology Medical Research Clinical Trials Public Health Patient Care Pharmaceuticals Cell Biology Patient Outcomes Medical Treatments Oncology
NIH-funded research shows a modest reduction in obesity-related cancer risk and all-cause mortality among diabetic adults using GLP-1 receptor agonists, with notable benefits for women.